White Cloud Mountain Pharmaceutical Group Independent Director Huang Longde's 2025 Annual Performance Report Released

China Visit Network Data
Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. recently released the 2025 annual performance report of independent director Mr. Huang Longde. The report shows that during the reporting period, Mr. Huang Longde strictly complied with relevant laws and regulations and the company charter, and diligently fulfilled his duties as an independent director. In 2025, Mr. Huang Longde personally attended all 14 board meetings and all 3 shareholders’ meetings, with no instances of absence. As a member of the company’s audit committee and budget committee, he also attended all relevant special committee meetings. During the reporting period, Mr. Huang Longde focused on several corporate governance matters. He participated in deliberations and issued independent opinions, covering related-party transactions such as the company’s capital increase to Guangzhou Baiyunshan Biotech Co., Ltd., participation in the establishment of an equity investment fund, and the expected 2026 daily related-party transactions. During the annual report audit work, he conducted extensive communication with the internal audit organizations and the annual audit accounting firm, and reviewed the first draft of the financial and accounting report. In addition, he also issued consent opinions on matters including the company’s reappointment of Dah Xin Certified Public Accountants as the 2025 audit institution, nominating Cheng Hongjin, Tang Heping, and Chen Jiehui as candidates for executive directors, and the remuneration plans for directors and senior management, among others. He believed that the relevant procedures were lawful and compliant and were in line with the interests of the company and all shareholders. In the report, Mr. Huang Longde stated that his appointment met the requirements for independence and that, through attending shareholders’ meetings, performance briefings, and on-site inspections, he maintained communication with minority shareholders. Looking ahead to 2026, he pledged to continue to perform his duties diligently, provide advice for the board’s decision-making, and safeguard the company’s overall interests as well as the lawful rights and interests of minority shareholders.

A wealth of information and precise analysis—only on the Sina Finance app